Keyphrases
Older Women
100%
Antinociceptive
95%
Differential Diagnosis
75%
Desensitization
61%
Δ9-tetrahydrocannabinol (Δ9-THC)
60%
Intolerance
60%
Cisplatin
60%
Cannabinoid Receptor 2
55%
Cannabinoid Receptor 1 (CB1R)
55%
Sex Differences
50%
JWH133
50%
Inflammatory Pain
50%
Opioids
50%
WIN55,212-2
50%
Chronic Neuropathic Pain
50%
Nystagmus
50%
Acute Vestibular Syndrome
50%
Etiology
50%
Clinical Reasoning
50%
Back Pain
50%
Diagnostic Test
50%
Tunnel Vision
50%
Increased Intracranial Pressure
50%
Leptomeningeal Enhancement
50%
Multiple Sclerosis
50%
Headache
50%
Conference Proceedings
50%
Formalin Test
40%
CP55940
40%
Morphine
35%
Mutant Mice
30%
Anti-allodynic Effect
26%
Saccades
25%
Localizing Value
25%
Smooth Pursuit
25%
Brainstem
25%
Positional Testing
25%
Auditory Function
25%
Ocular Lateropulsion
25%
Spontaneous Nystagmus
25%
Head Shaking
25%
Chronic Dizziness
25%
Accurate Localization
25%
Ocular Alignment
25%
Cerebellar Structures
25%
Bedside Test
25%
Provocative Maneuvers
25%
Test of Skew
25%
Ocular Motor
25%
Elevated Protein
25%
Medicine and Dentistry
Differential Diagnosis
75%
Morphine
50%
Inflammatory Pain
50%
Cannabinoid 2 Receptor Agonist
50%
Clinician
50%
Saccadic Eye Movement
50%
Dizziness
50%
Smooth Pursuit Eye Movement
50%
Brainstem
50%
Nystagmus
50%
Hearing
50%
Vertigo
50%
Intracranial Hypertension
50%
Diagnosis
50%
Backache
50%
Symptom
50%
Clinical Reasoning
50%
Headache
50%
Multiple Sclerosis
50%
Head Position
50%
Fundus Photography
50%
Formaldehyde
42%
Cannabinoid 2 Receptor
42%
Physical Examination
25%
Vision Disorder
25%
Emergency Department
25%
Lymphocytic Pleocytosis
25%
Erythrocyte Sedimentation Rate
25%
Magnetic Resonance Imaging
25%
C Reactive Protein
25%
Arm Weakness
25%
Cerebrospinal Fluid
25%
Antinociception
21%
Cross-Tolerance
21%
μ-Opioid Receptor
21%
Central Nervous System
14%
Cannabinoid 1 Receptor
14%
Standing
8%
Side Effect
7%
Hypothermia
7%
Somatics
7%
Stereotypic Movement Disorder
7%
Treatment of Pain
7%
Withdrawal Syndrome
7%
Morphine Tolerance
7%
Neuroscience
Tetrahydrocannabinol
62%
Cisplatin
62%
Neuropathic Pain
62%
Smooth Pursuit
50%
Saccade
50%
Agonist
50%
Cannabinoid 1 Receptor
50%
Brainstem
50%
Cannabinoid
48%
Retina S Antigen
18%
G Protein-Coupled Receptor Kinase
12%
Allodynia
12%
Alanine
12%
Serine
12%
Receptor
12%
Rimonabant
5%
Neuropathy
5%
Hypothermia
5%
Inverse Agonist
5%
Cannabinoid Receptor Type 1
5%
